Foot Core Stabilization Exercises Vs. Shockwave Therapy for Pain, Strength, and Function in Plantar Fasciitis
Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Mar 17, 2025
Trial Information
Current as of April 29, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different treatments for plantar fasciitis, a common condition that causes heel pain. The researchers want to see how effective foot core stabilization exercises compare to shockwave therapy in reducing pain, improving muscle strength, and helping people regain their normal function. By exploring these two approaches, the study aims to find better ways to treat plantar fasciitis and improve the quality of life for those affected.
To participate in the trial, you need to be an adult aged 25 to 60 who has been diagnosed with plantar fasciitis by a qualified doctor. You should have heel pain that has lasted for at least three months and gets worse when you take your first steps in the morning or after resting. Unfortunately, if you've had foot or ankle surgery, certain medical conditions like diabetes or cancer, or if you've tried other treatments without improvement, you may not be eligible for this study. If you join, you can expect to receive either the exercises or the shockwave therapy and help contribute to important research that could benefit many others suffering from this painful condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 25 to 60 years who have been diagnosed with plantar fasciitis by a physician specializing in physical medicine and rehabilitation or an orthopedic specialist.
- • Heel pain localized to the medial calcaneal tubercle, persisting for three months or longer.
- • Pain that worsens with the first steps taken in the morning or after periods of rest.
- Exclusion Criteria:
- • Individuals who have undergone foot or ankle surgery.
- • Individuals with a history of chronic or active infection in the treatment area.
- • Individuals with Type 1 or Type 2 Diabetes Mellitus, systemic inflammatory arthritis, cancer, active tuberculosis, or a history of neurological or vascular diseases.
- • Individuals who have undergone conservative treatment including nonsteroidal anti-inflammatory drugs for 6 months with no significant improvement.
- • Patients with numbness or tingling in the lower extremity, with or without provocation, or those with undiagnosed pain.
- • Pregnancy.
About Istanbul Medipol University Hospital
Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bursa, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported